Página 21 dos resultados de 4394 itens digitais encontrados em 0.015 segundos
Resultados filtrados por Publicador: American Society of Hematology

‣ Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia

Caligiuri, Michael A.; Briesewitz, Roger; Yu, Jianhua; Wang, Lisheng; Wei, Min; Arnoczky, Kristy J.; Marburger, Trent B.; Wen, Jing; Perrotti, Danilo; Bloomfield, Clara D.; Whitman, Susan P.
Fonte: American Society of Hematology Publicador: American Society of Hematology
Tipo: Artigo de Revista Científica
Publicado em 01/08/2007 Português
Relevância na Pesquisa
381.26105%
The CBL ubiquitin ligase targets a variety of activated tyrosine kinases (TKs) for degradation. Many TKs are mutationally or autocrine activated and/or often overexpressed at the mRNA and protein levels in acute leukemias. We hypothesized that CBL is mutated in patients with acute myeloid leukemia (AML). Four of 12 patients and the MOLM-13 cell line harbored c-CBL mutations, either RNA splicing mutations, missense mutations, or a nucleotide insertion. Additionally, 1 of the 12 patients harbored a missense mutation in the related CBL-b gene. Each c-CBL mutation involves the structurally important α-helix within the linker region, while the mutation in CBL-b was located in the Ub-E2 protein-binding RING finger. Short-interfering RNA knockdown of mutant c-CBL present in MOLM-13 cells was growth inhibitory. In summary, novel mutations in c-CBL and CBL-b have been identified in human AML and may represent potential targets for novel therapeutics.